The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: The PROTECT II Study
Open accessAbstract
Background—: Although coronary artery bypass grafting is generally preferred in symptomatic patients with severe, complex multivessel, or left main disease, some patients present with clinical features that make coronary artery bypass grafting clinically unattractive. Percutaneous coronary intervention with hemodynamic support may be feasible for these patients. Currently, there is no systematic comparative evaluation of hemodynamic support devices for this indication. Methods and Results—: We randomly assigned 452 symptomatic patients with complex 3-vessel disease or unprotected left main coronary artery disease and severely depressed left ventricular function to intra-aortic balloon pump (IABP) (n=226) or Impella 2.5 (n=226) support during nonemergent high-risk percutaneous coronary intervention. The primary end point was the 30-day incidence of major adverse events. A 90-day follow-up was required, as well, by protocol. Impella 2.5 provided superior hemodynamic support in comparison with IABP, with maximal decrease in cardiac power output from baseline of −0.04±0.24 W in comparison with −0.14±0.27 W for IABP ( P =0.001). The primary end point (30-day major adverse events) was not statistically different between groups: 35.1% for Impella 2.5 versus 40.1% for IABP, P =0.227 in the intent-to-treat population and 34.3% versus 42.2%, P =0.092 in the per protocol population. At 90 days, a strong trend toward decreased major adverse events was observed in Impella 2.5–supported patients in comparison with IABP: 40.6% versus 49.3%, P =0.066 in the intent-to-treat population and 40.0% versus 51.0%, P =0.023 in the per protocol population, respectively. Conclusions—: The 30-day incidence of major adverse events was not different for patients with IABP or Impella 2.5 hemodynamic support. However, trends for improved outcomes were observed for Impella 2.5–supported patients at 90 days. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00562016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Hochman, J. S., Sleeper, L. A., Webb, J. G., Sanborn, T. A., White, H. D., Talley, J. D., Buller, C. E., Jacobs, A. K., Slater, J. N., Col, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410901 · Cited by 3,131
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Self-citationCoronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
Velazquez, E. J., Lee, K. L., Deja, M. A., Jain, A., Sopko, G., Marchenko, A., Ali, I. S., Pohost, G., Gradinac, S., Abraham, W. T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100356 · Cited by 1,304
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 532
Self-citationPerera, D., Stables, R., Thomas, M., Booth, J., Pitt, M. K., Blackman, D. J., de Belder, A., & Redwood, S. R. (2010) · JAMA · doi:10.1001/jama.2010.1190 · Cited by 389
A contemporary overview of percutaneous coronary interventions
Anderson, H. V., Shaw, R. E., Brindis, R. G., Hewitt, K., Krone, R. J., Block, P. C., McKay, C. R., & Weintraub, W. S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01733-3 · Cited by 299
Supported High-Risk Percutaneous Coronary Intervention With the Impella 2.5 Device
Sjauw, K. D., Konorza, T. F. M., Erbel, R., Danna, P., Viecca, M., Minden, H., Butter, C., Engstrøm, T., Hassager, C., Machado, F. P., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.018 · Cited by 229
Self-citationRole of cardiac power in heart failure
Cotter, G., Williams, S. G., Vered, Z., & Tan, L. B. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200305000-00007 · Cited by 167
Maini, B. S., Naidu, S. S., Mulukutla, S. R., Kleiman, N. S., SCHREIBER, T. L., Wohns, D., Dixon, S. R., Rihal, C. S., Dave, R. M., & O’Neill, W. W. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23403 · Cited by 163
Self-citationSample size recalculation using conditional power
Denne, J. S. (2001) · Statistics in Medicine · doi:10.1002/sim.734 · Cited by 134
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
Rihal, C. S., Naidu, S. S., Givertz, M. M., Szeto, W. Y., Burke, J. A., Kapur, N. K., Kern, M., Garratt, K. N., Goldstein, J. A., Dimas, V., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.036 · Cited by 681
Vahdatpour, C., Collins, D., & Goldberg, S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.011991 · Cited by 431
Amin, A. P., Spertus, J. A., Curtis, J. P., Desai, N., Masoudi, F. A., Bach, R. G., McNeely, C., Al-Badarin, F., House, J. A., Kulkarni, H., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044007 · Cited by 421
Current Status of Rotational Atherectomy
Tomey, M. I., Kini, A. S., & Sharma, S. K. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.12.196 · Cited by 312
Galassi, A. R., Werner, G. S., Boukhris, M., Azzalini, L., Mashayekhi, K., Carlino, M., Avran, A., Konstantinidis, N. V., Grancini, L., Bryniarski, L., et al. (2019) · EuroIntervention · doi:10.4244/eij-d-18-00826 · Cited by 293
Kapur, N. K., Alkhouli, M. A., DeMartini, T. J., Faraz, H., George, Z. H., Goodwin, M. J., Hernandez-Montfort, J. A., Iyer, V. S., Josephy, N., Kalra, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038269 · Cited by 278
Self-citationTemporary circulatory support for cardiogenic shock
Combes, A., Price, S., Slutsky, A. S., & Brodie, D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31047-3 · Cited by 257
Metadata
- Authors
- O'Neill, W. W., Kleiman, N. S., Moses, J., Henriques, J. P. S., Dixon, S., Massaro, J., Palacios, I., Maini, B., Mulukutla, S., Džavík, V., Popma, J., Douglas, P. S., & Ohman, M.
- Venue
- Circulation
- Published
- 2012-10-02
- Volume
- 126
- Issue
- 14
- Pages
- 1717-1727
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2038381502
- Cited by
- 878
- References
- 11
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.